CG Oncology, Inc. (CGON) vs Scholar Rock Holding Corporation (SRRK)
CG Oncology, Inc. and Scholar Rock Holding Corporation are both Biotechnology companies. CG Oncology, Inc. and Scholar Rock Holding Corporation are of similar size ($6.1B and $6.0B). CG Oncology, Inc. grew revenue faster over the last twelve months: 840.8% against 213.7%. Scholar Rock Holding Corporation has the higher net margin (0.00% vs −3,602.7%) and the higher return on invested capital (0.00% vs −4,111.6%). Across the 17 metrics below, Scholar Rock Holding Corporation leads on 9 and CG Oncology, Inc. on 8.
Valuation
Profitability
| Metric | CGON | SRRK | Biotechnology median |
|---|---|---|---|
| Gross margin | (85.20%) | 0.00% | 65.16% |
| Operating margin | (4,056.18%) | 0.00% | 0.00% |
| Net margin | (3,602.68%) | 0.00% | 0.00% |
| Free cash flow margin | (2,879.62%) | 0.00% | 0.00% |
| Return on equity | (26.41%) | (167.77%) | (57.72%) |
| Return on assets | (25.11%) | (94.63%) | (49.22%) |
| Return on invested capital | (4,111.64%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack